Tweet
Just wanted to share this article I came across about a tear neurostimulator device Allergan has been working on:
Here is a follow-up article from July on their application to the FDA for approval. I think I read somewhere that the device would be released this summer (2017), but cannot remember the source. Does anyone have more up-to-date information on this?
Allergan announced today that two pivotal trials of the Oculeve Intranasal Tear Neurostimulator each met their primary and secondary efficacy endpoints. With these new results, a premarket submission for the device is on-track to be submitted to the Food and Drug Administration (FDA) in the second half of 2016.
This handheld stimulator and daily disposable tips increases tear production upon stimulation in patients with Dry Eye Disease due to decreased tear production. There have been several Oculeve Intranasal Tear Neurostimulator clinical studies completed with more than 200 adult patients, showing positive safety and efficacy of the device.
This handheld stimulator and daily disposable tips increases tear production upon stimulation in patients with Dry Eye Disease due to decreased tear production. There have been several Oculeve Intranasal Tear Neurostimulator clinical studies completed with more than 200 adult patients, showing positive safety and efficacy of the device.